GL Ventures - a VC unit of Hillhouse Capital - and China State-Owned Capital Venture Investment Fund have led a RMB400 million ($61 million) Series C round for Thousand Oaks Biopharmaceuticals, a China-based contract development and manufacturing organization (CDMO).
CDH Investments, HighLight Capital, China-US Green Fund, and Sany Foundation also took part as new investors. Existing backers Goldstone Investment, CICC Capital, and a fund under Fosun Group all re-upped....
Australia’s Go1 gains traction with a B2B approach to a rapidly expanding human resources and workforce management software industry. SoftBank Vision Fund 2 is among the believers
Having agreed to provide a succession solution to the founder of Korean furniture retailer and interior designer Hanssem, IMM Private Equity wants to harness growth through demographics and differentiation
The lack of a reliable IPO channel is a longstanding exit obstacle for venture capital investors in India. Domestic listings may, unexpectedly, prove to be the answer
Semiconductors are a popular investment target in China on the back of US decoupling and a push for self-sufficiency. Alex Banh, a managing partner of sector specialist IPV Capital, shares his views